CVE-2023-38955
ZKTeco
- Published
- 3 August 2023
- Last modified
- 9 July 2026
- CVSS
- 7.5 v3.1
- Severity
- high
- EPSS
- 0.6% (46th pct)
- CISA KEV
- Not listed
- NVD status
- Modified
- Weaknesses
- CWE-668
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Description
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
Exploitation
Not listed in the CISA Known Exploited Vulnerabilities catalogue as of 2026.09.04. That is an absence of confirmed public exploitation, not evidence that exploitation has not occurred. EPSS models a 0.6% probability of exploitation activity in the next 30 days.
Affected products
| Product | Vendor | Type | Versions named |
|---|---|---|---|
| Bioaccess Ivs | ZKTeco | unknown | 3.3.1 |
References
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38955 third-party
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38955 third-party
Record assembled from NVD, CISA KEV 2026.09.04 and FIRST EPSS 2026-09-04. Affected products are those NVD's CPE configuration names that fall inside this site's scope; a CVE may affect products outside it.